BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 20302683)

  • 21. Double-blind trials of azelastine nasal spray monotherapy versus combination therapy with loratadine tablets and beclomethasone nasal spray in patients with seasonal allergic rhinitis. Rhinitis Study Groups.
    Berger WE; Fineman SM; Lieberman P; Miles RM
    Ann Allergy Asthma Immunol; 1999 Jun; 82(6):535-41. PubMed ID: 10400480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of azelastine 0.15% nasal spray and azelastine 0.10% nasal spray in patients with seasonal allergic rhinitis.
    Shah S; Berger W; Lumry W; La Force C; Wheeler W; Sacks H
    Allergy Asthma Proc; 2009; 30(6):628-33. PubMed ID: 19930788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of azelastine nasal spray on symptoms and quality of life compared with cetirizine oral tablets in patients with seasonal allergic rhinitis.
    Berger W; Hampel F; Bernstein J; Shah S; Sacks H; Meltzer EO
    Ann Allergy Asthma Immunol; 2006 Sep; 97(3):375-81. PubMed ID: 17042145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of azelastine versus triamcinolone nasal spray in allergic and nonallergic rhinitis.
    Kalpaklioglu AF; Kavut AB
    Am J Rhinol Allergy; 2010; 24(1):29-33. PubMed ID: 20109317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of azelastine 0.15% nasal spray administered once daily in subjects with seasonal allergic rhinitis.
    van Bavel J; Howland WC; Amar NJ; Wheeler W; Sacks H
    Allergy Asthma Proc; 2009; 30(5):512-8. PubMed ID: 19747429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the drug monitoring programme of azelastine hydrochloride nasal spray in the treatment of allergic rhinitis in children under 13 years of age.
    Wober W; Diez Crespo CD; Bähre M
    Arzneimittelforschung; 1997 Jul; 47(7):841-4. PubMed ID: 9272242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluticasone furoate nasal spray is more effective than fexofenadine for nighttime symptoms of seasonal allergy.
    Andrews CP; Martin BG; Jacobs RL; Mohar DE; Diaz JD; Amar NJ; Kaiser HB; Vandewalker ML; Bernstein J; Toler WT; Prillaman BA; Dalal AA; Lee LA; Philpot EE
    Allergy Asthma Proc; 2009; 30(2):128-38. PubMed ID: 19463203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of intranasal olopatadine in the fixed-dose combination GSP301 versus two monotherapy intranasal olopatadine formulations.
    Patel P; Salapatek AM; Talluri RS; Tantry SK
    Allergy Asthma Proc; 2018 May; 39(3):224-231. PubMed ID: 29669667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis.
    Carr W; Bernstein J; Lieberman P; Meltzer E; Bachert C; Price D; Munzel U; Bousquet J
    J Allergy Clin Immunol; 2012 May; 129(5):1282-1289.e10. PubMed ID: 22418065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of fluticasone furoate 110 microg once daily in the treatment of nasal and ocular symptoms of seasonal allergic rhinitis in adults and adolescents sensitized to mountain cedar pollen.
    Jacobs R; Martin B; Hampel F; Toler W; Ellsworth A; Philpot E
    Curr Med Res Opin; 2009 Jun; 25(6):1393-401. PubMed ID: 19419338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Olopatadine-mometasone combination nasal spray: Evaluation of efficacy and safety in patients with seasonal allergic rhinitis.
    Hampel FC; Pedinoff AJ; Jacobs RL; Caracta CF; Tantry SK
    Allergy Asthma Proc; 2019 Jul; 40(4):261-272. PubMed ID: 31053180
    [No Abstract]   [Full Text] [Related]  

  • 32. An integrated analysis of the efficacy of fluticasone furoate nasal spray on individual nasal and ocular symptoms of seasonal allergic rhinitis.
    Maspero JF; Walters RD; Wu W; Philpot EE; Naclerio RM; Fokkens WJ
    Allergy Asthma Proc; 2010; 31(6):483-92. PubMed ID: 21708060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast.
    Ratner PH; Howland WC; Arastu R; Philpot EE; Klein KC; Baidoo CA; Faris MA; Rickard KA
    Ann Allergy Asthma Immunol; 2003 May; 90(5):536-42. PubMed ID: 12775135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine.
    LaForce CF; Corren J; Wheeler WJ; Berger WE;
    Ann Allergy Asthma Immunol; 2004 Aug; 93(2):154-9. PubMed ID: 15328675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of olopatadine-mometasone combination nasal spray for the treatment of seasonal allergic rhinitis.
    Gross GN; Berman G; Amar NJ; Caracta CF; Tantry SK
    Ann Allergy Asthma Immunol; 2019 Jun; 122(6):630-638.e3. PubMed ID: 30910440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine.
    Berger WE; White MV;
    Ann Allergy Asthma Immunol; 2003 Aug; 91(2):205-11. PubMed ID: 12952117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluticasone furoate nasal spray: a single treatment option for the symptoms of seasonal allergic rhinitis.
    Kaiser HB; Naclerio RM; Given J; Toler TN; Ellsworth A; Philpot EE
    J Allergy Clin Immunol; 2007 Jun; 119(6):1430-7. PubMed ID: 17418384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioavailability and disposition of azelastine and fluticasone propionate when delivered by MP29-02, a novel aqueous nasal spray.
    Derendorf H; Munzel U; Petzold U; Maus J; Mascher H; Hermann R; Bousquet J
    Br J Clin Pharmacol; 2012 Jul; 74(1):125-33. PubMed ID: 22356350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of azelastine nasal spray at a dose of 1 spray per nostril twice daily.
    Lumry W; Prenner B; Corren J; Wheeler W
    Ann Allergy Asthma Immunol; 2007 Sep; 99(3):267-72. PubMed ID: 17910331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved quality of life among seasonal allergic rhinitis patients treated with olopatadine HCl nasal spray 0.4% and olopatadine HCl nasal spray 0.6% compared with vehicle placebo.
    Hampel FC; Ratner PH; Amar NJ; van Bavel JH; Mohar D; Fairchild CJ; Wall GM; Brubaker MJ; Drake M; Crenshaw KM
    Allergy Asthma Proc; 2006; 27(3):202-7. PubMed ID: 16913262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.